Doxorubicin

6 clinical trials · Condition

Record	Firm	Date
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) (NCT00590785)	National Cancer Institute (NCI)	1996-08-13

Every clearance here is in the API, with alerts when new ones post.